Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM, Mass. and DUBLIN, Ireland, April 04, 2024 -- Mural Oncology plc , a clinical-stage immuno-oncology company leveraging its core competencies in immune cell modulation and protein...

Related Keywords

Dublin ,Ireland ,Katie Sullivan ,David Borah ,Linkedin ,Nasdaq ,Stock Option ,Incentive Plan ,Nasdaq Listing Rule ,Mural Oncology ,Markets ,